D
Voyageur Pharmaceuticals Ltd. VM.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

02/28/2025 11/30/2024 08/31/2024 05/31/2024 02/29/2024
Net Income -571.30K -333.30K -261.00K -412.70K -244.80K
Total Depreciation and Amortization 200.00 300.00 300.00 300.00 300.00
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 282.70K 60.20K 15.80K 180.30K 94.00K
Change in Net Operating Assets -675.10K 331.80K 236.80K 93.20K 14.30K
Cash from Operations -963.50K 59.00K -8.10K -138.90K -136.30K
Capital Expenditure -29.60K -25.70K -40.20K -28.00K -27.90K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -29.60K -25.70K -40.20K -28.00K -27.90K
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 1.61M 0.00 5.60K -- 493.60K
Repurchase of Common Stock -- -- -- -5.60K --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 283.90K 116.70K 50.30K -3.60K -25.30K
Cash from Financing 1.32M 84.80K 40.80K -6.70K 348.60K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments 0.00 -- -- 0.00 --
Net Change in Cash 330.80K 118.10K -7.40K -173.60K 184.30K